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SI–I Meta-analysis procedures 
 
A. Search and selection of studies: 
We searched papers with (i) ISI Web of Knowledge and Google Scholar using combinations of 
multiple keywords: human, telomeres, telomere length, age, ag(e)ing, survival, mortality, and 
(ii) by checking references of relevant papers. In addition, (iii) we checked all the papers that 
cited (Cawthon et al., 2003), the first paper showing an association of human telomere length 
with mortality. The last search was carried out on 2-Feb-2012. 
From the retrieved papers we selected studies that contained human leucocyte telomere 
length (TL) measurements combined with a follow-up period in which mortality was recorded. 
Further inclusion criteria were: (i) the study used “healthy” subjects, i.e. studies in which 
subjects were not selected for carrying a particular disease or other health problem. Causes of 
death were unfortunately available in only a few cases, thus we could not take into account 
whether these were aging-related or not. We note however that since this increases 
measurement error, this makes our test more conservative, i.e. decreases type-I error 
probability. (ii) Whether the necessary data could either be extracted from the paper, or 
received after contacting the authors, which was the case for each otherwise eligible study. See 
Table S1 below for an overview of the studies and study-specific details on data extraction. 
 
B. Data extraction and effect size calculations: 
From each study we extracted: the natural logarithm (ln) of the hazard ratio and its 95% 
confidence interval associated with TL, the mean age of the study population at TL sampling, 
the length of the follow up period, and the TL assay method (qPCR, Southern Blot, or flow-
FISH). Studies differed in the number of covariates included in the survival analysis, possibly 
rendering the TL estimates across studies to be incomparable. Therefore, we used only the 
simplest survival models reported, in which besides TL only age was taken into account. 
Studies varied in whether they used TL as continuous variable or instead compared TL 
quantiles, which in principle renders the hazard ratio estimates to be incomparable, because the 
units of analysis differ (Kavvoura & Liberopoulos, 2007). We therefore determined for each 
study the unit of analysis and converted the HR’s accordingly (see Table S1 for details). For 
example, 1.23 in table S1 denotes that the HR was based on 1.23 kbp TL difference (if this was 
not reported in the paper we estimated it based on the reported mean TL and standard 
deviation, assuming a normal distribution). All analyses and figures were based on these 
converted HR values, but we note that this conversion had only minor effects on the results. 
 
C. Meta-analysis: 
We performed meta-analyses using the Metafor package (Viechtbauer, 2010) in R (R 
development core team, 2011) using a random-effects model fitted with restricted maximum 
likelihood. Sampling variances were calculated from the confidence intervals, and we used 
1/s.e.^2 as weighting factor in the meta-analysis (Hedges & Olkin, 1985). Heterogeneity was 
evaluated using Q tests. With respect to testing whether the association of TL and mortality 
diminished with age we used the natural logarithm of age rather than age, because when the ln 
HR declines with age it can be expected that it will asymptotically approach zero, and this is 
better captured by ln age when compared to age. 
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Table S1. Studies used in the meta-analysis. Sample sizes are the total numbers of individuals sampled. Ln HR (C.I.) denotes the natural 
logarithm of hazard ratio of TL with the 95% confidence interval in brackets. The letters a-c denote method of HR extraction: a=HR directly 
from paper, b=HR from author, c=HR calculated by us (see below for details). TL assay denotes whether TL was determined using quantitative 
pcr (q-pcr), southern blot (s-blot), or flow-cytometry (flow-FISH). Mean age denotes the mean age in years at blood draw of the sampled 
subjects. Follow-up is the number of years after blood draw during which survival was recorded. Unit of analysis denotes the difference in TL in 
kbp that was used as unit of analysis in the study’s survival analysis (as determined by us). Corrected ln HR (C.I.) denotes the study ln HR 




 The cohort of Danish twins analyzed by Bischoff et al. was studied again later by Kimura et al. However, the paper by Bischoff et al included a separate analysis for 
centenarians, which was not replicated and we used only this study effect size in our meta-analysis. Survival and TL of centenarians were taken from figure 1 in the paper of 
Bischoff et al. HR was determined using a Cox-proportional hazard model without censoring of the data (all individuals died).  




Study Sample size ln HR (C.I.)  TL assay Mean age Follow-up Unit of analysis (kbp) Corrected ln HR (C.I.) 
(Bakaysa et al., 2007) 350 0.531 (0.182:0.956) a s-blot 78.8 6.9 1.23 0.430 (0.148:0.774) 
(Bischoff et al., 2006)1 42 -0.101 (-0.375:0.189) c s-blot 101.0 6.0 1.00 -0.101 (-0.375:0.189) 
(Cawthon et al., 2003) 143 0.621 (0.199:1.040) a q-pcr 71.9 15.0 1.55 0.402 (0.129:0.676) 
(Epel et al., 2009) 235 0.329 (-0.067:0.725) b q-pcr 73.7 12.0 1.55 0.213 (-0.044:0.471) 
(Fitzpatrick et al., 2011) 1,136 0.278 (0.095:0.451) a s-blot 73.9 8.1 1 0.278 (0.095:0.451) 
(Harris et al., 2006) 190 0.092 (-0.147:0.330) b q-pcr 79.0 5.0 1 0.092 (-0.147:0.330) 
(Honig et al., 2006)2 132 -0.223 (-1.204:0.588) a q-pcr 81.4 NA 2.08 -0.107 (-0.578:0.282) 
(Houben et al., 2011) 203 -0.215 (-0.673:0.248) a q-pcr 78.5 7.0 0.9 -0.239 (-0.747:0.276) 
(Kimura et al., 2008)1 548 0.211 (-0.030:0.446) a s-blot 78.8 7.3 1 0.211 (-0.030:0.446) 
(Martin-Ruiz et al., 2005) 598 0.000 (-0.166:0.236) a q-pcr 89.8 13.0 2 0.000 (-0.083:0.118) 
(Martin-Ruiz et al., 2011) 751 0.365 (-0.198:0.936) b q-pcr 85.0 1.5 1.45 0.252 (-0.137:0.646) 
(Njajou et al., 2009) 2,721 0.000 (-0.105:0.095) a q-pcr 73.6 10.0 1 0.000 (-0.105:0.095) 
(Strandberg et al., 2011) 622 0.000 (-0.186:0.174) b s-blot 75.6 7.0 1 0.000 (-0.186:0.174) 
(Willeit et al., 2010) 787 0.467 (0.010:0.673) a q-pcr 62.6 10.0 1.07 0.435 (0.009:0.626) 
(Woo et al., 2008) 2,006 0.166 (-0.493:0.878) a q-pcr 72.4 4.0 4.9 0.034 (-0.099:0.176) 
(Zekry et al., 2012) 444 0.058 (-0.261:0.365) a flow-FISH 85.3 5.0 2.08 0.028 (-0.125:0.175) 
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D. Meta-analysis results: 
We tested for publication bias using a funnel plot in combination with a rank test (Viechtbauer, 
2010), and no publication bias was detected (Fig. S1 below; Kendall's tau = 0.150; P = 0.450). 
There was significant heterogeneity among effect sizes (Q = 33.1; P = 0.005). Residual 
heterogeneity was substantially reduced when adding subject sampling age to the model, but 
remained significant (–18%, Q = 27.2; P = 0.018), suggesting that in addition to subject 
sampling age, differences in study methods and, or, population differences may affect the 
association of TL and mortality. We tested for such study differences, i.e. TL assay method and 
study follow-up period, but these were not significant as main effect (TL assay method P = 











SI–II Simulation study procedures  
 
A. General simulation procedures: 
With the simulation models of biological age and somatic redundancy (described in SI–III and 
–IV respectively), we simulated survival times per individual per study, using the number of 
individuals, mean subject sampling age, and follow-up period as in the studies used in the 
meta-analysis. In the simulation, we generated individual survival data from one age to the next 
by using the age and TL specific mortality probability (determined by either one of the model 
equations 1, 2, or 3 described in SI–III and –IV) and a random value drawn from the uniform 
distribution U(0,1). Each study was simulated 50 times and we calculated the HR of TL using 
Cox’s proportional hazards with right censoring (Kleinbaum & Klein, 2005) per simulation 
cycle, and subsequently we averaged these HR’s over the 50 simulations. Thus, we obtained a 
simulated data set for each parameter combination for each of the models. We then optimized 
the parameters to maximize the resemblance between the simulated data and the meta-
regression line of the real data, and subsequently compared which of the models generated data 
that best matched the observed pattern. 
  
 
B. Model optimization: 
To enable a quantitative comparison with the meta-regression results we optimized the model 
parameters for the simulated HR values to yield the closest possible fit to the meta-regression 
line of the observed studies. This was achieved by minimizing the sum of the weighted squared 
differences between the simulated study HR’s and the meta-regression line fitted through the 
observed HR’s. The weight factor that we applied to these squared differences was the same 
weight factor as used in the meta-analysis of the corresponding empirical studies, i.e. 1/s.e.2. To 
find the optimal parameter values we started with a wide range of parameter combinations and 
applied bisectioning to find the optimal parameter values. 
 Theoretically, a good fit of the simulated data to the meta-regression line of the 
observed studies could be based on lifespan distributions in the simulated data that strongly 
deviate from the empirically observed lifespan, which would render the model uninformative. 
We avoided this problem by additionally fitting the simulated lifespan distributions to the 
observed lifespan distribution obtained from the Dutch bureau of statistics (Dutch bureau of 
statistics, 1996-2009) and omitted all model parameter combinations that yielded a fit of r < 
0.90. We were limited to this selection of models, because a quantitative approach, i.e. directly 
optimizing the simulation model to the observed lifespan, requires the lifespan data of the 
studies that we used in our meta-analysis, and these are unavailable.  Since all studies were 
done in recent years, and in Western countries, we consider it is safe to assume that these 
distributions are sufficiently similar when compared to our selection criterion. We calculated r 
as follows 
 
r = 1−SSe/SStot 
where SSe is the sum of the squared differences between the observed and simulated 
probability density lifespan distributions, and SStot is the sum of squared differences between 
the observed probability density lifespan distribution and its mean. For the calculations of r we 
used matched age ranges of the simulated- and the observed lifespan distributions, and thus 
observed age at deaths of age < 63 and simulated age at deaths of age > 98 were ignored. 
C. Model comparison: 
To formally compare the fit of the simulation models to the observed pattern we performed 
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additional meta-regression analyses of the observed hazard ratios, pooled with the hazard ratios 
generated by one of the simulation models with the optimized parameters. Pooling data and 
then fitting one meta-regression is informative, because when the simulated data fit the 
observed data less well this results in a poorer total fit. As measure of goodness of fit we used 
Akaike’s “An Information Criterion” (AIC) (Akaike, 1974), calculated on the basis of the 
maximum log-likelihood (Metafor package in R). Following general convention, we considered 




SI–III Simulation model 1: biological age 
 
A. Weibull: 
We here describe how in our model TL determines biological age and how this was 
implemented in the Weibull distribution. At the start of each simulation, for each study, TL was 
generated from a normal distribution with the mean and SD approximating the mean TL and 
SD of the actual studies (TL mean=6.6 kbp, SD=1.0 kbp). TL shortening was included of 40 
base pairs per year, which approximates the measured TL shortening rate in some longitudinal 
studies, e.g. (Aviv et al., 2009; Chen et al., 2011; Ehrlenbach et al., 2009; Houben et al., 2011). 
We stress however that the exact value has no effect on the outcome of the simulations, 
because the entire distribution shifted to shorter TL with increasing age, but the exact same 
range and relative differences between means were maintained. As measure of TL we used the 




where Tt is TL (kbp) at age t, and  is the population mean TL at age t. Subsequently we 




where t is age in years and b1 > 0 is the parameter indicating how many years the age is 
adjusted per . This would generate negative biological ages early in life but not in our 
simulations in which the lowest age is 63 years. At young age (after birth) we assume the effect 
of TL on biological age to increase non-linearly with age, levelling-off at medium to older 
ages, but note that we cannot test this because data on ages < 63 are unavailable.  
We based equation (1) below on the Weibull distribution, which has been shown to 
describe the distribution of human life span well (Weibull, 1951), but for comparison repeated 
the analysis using the Gompertz distribution (see below). We assumed the hazard rate h(t) to 




where λ and p are the Weibull scale and shape parameters respectively. In this model the effect 
of TL on mortality diminishes with age, because for p > 1 mortality increases as a power 
function of age while the modulating effect of TL on mortality does not. This results in TL 
becoming relatively less important for survival, because the mortality risk of other factors 
increases with age, suggesting qualitative agreement between the biological age model and the 
observed pattern. The parameter range that we tested for this model was [λ (10·10-3, 17·10-3); p 
(1, 10); b1 (1, 10)]. The optimal parameter values were: λ = 14.29·10-3; p = 4.0; b1 = 3.0, 
resulting in a fit to the meta-regression line with AIC = -46.8 (calculated as described in SI–




Alternatively we based our model of biological age on the Gompertz function, because some 
discrepancy between these functions exists when fitting to old ages (Juckett, 1993). We used 
the same definition of biological age as previously described, and in the Gompertz model the 
hazard rate h(t) increases with biological age  as follows: 
δTt ≡ Tt − Tt
Tt
t ' ≡ t − b1δTt
δTt
t '
(1)   h(t) = λ p(λt ')p−1
t '
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(2)   h(t) = Reat '  
 
where R is the initial mortality rate and a is the age dependent mortality. The parameter range 
that we tested for this model was [R(1·10-4, 1·10-3); a(0.01, 0.2); b(1-15)]. The optimal 
parameter values were: R = 5·10-4; a = 0.045; b1 = 10.1, resulting in a fit to the meta-regression 







Fig. S2 HR of TL according to the biological age model based on the Weibull and Gompertz 
distributions. The data points are the study HR values and the solid line is the meta-regression 
line as in Figure 1 of the main paper.  
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SI–IV Simulation model 2: somatic redundancy 
The initial number of redundancy elements and the rate at which these fail characterizes a 
redundancy system. We considered TL as index of the number of redundancy elements, and we 
assumed the redundancy element failure rate to be constant, i.e. independent of age. This 
results in that the cumulative survivorship of a single redundancy element with failure rate k 
decreases with age exponentially (S(t)=e–kt) and the hazard function of an organism with 
multiple redundancy elements is therefore given by:  
 
(3)   h(t) = nke
−kct (1− e−kct )n−1






where t is age in years, k is the constant (age-independent) failure rate of n redundancy 
elements, and c is a scaling factor (Gavrilov & Gavrilova, 2001). As measure of TL we used 
the deviation from the population mean TL (kbp) at sampling age ( ). We set a to 
500, meaning that the average redundancy (at mean TL) at the start of our simulation was 500, 
and b2 > 0 determines the redundancy per unit . In this model the effect of TL on mortality 
diminishes with age because the variation in the number of redundancy elements between 
individuals diminishes with age, because individuals with a high level of redundancy also lose 
more elements per unit of time, compared to individuals with a low redundancy level. We 
optimized the parameters of equation (3) using the same procedure as used for the previous 
model (see SI II.C). The parameter range that we tested was [k (0.18, 0.25); c (0.25, 0.35); b2 
(15, 110)]. The optimal parameter values were: k = 0.235; c = 0.328; b2 = 90, resulting in a fit 
to the meta-regression line with AIC = -50.8 (see SI–II.D for details on calculations of the 
AIC).  
The fit of the redundancy model in Fig. 1 is a meta-regression fit using the simulated 
data, which explains why the line goes below zero at ages > 92, instead of approaching zero 




n ≡ a + b2δT







Figure S3. Exact ln HR of TL as calculated by the redundancy model (solid line). The data 
points are the study HR values as in Figure 1. The line asymptotically approaches zero because 
the rate at which total redundancy diminishes asymptotically approaches the redundancy 
element failure rate. This results in that at very old age all individuals face the same mortality 
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